ARCT

Conviction 34HealthcareScan · Mon, Aug 10, 2026

ARCT$7.06-4.79%

ResistanceSupportVol 14

Vol MA14 522.39K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Arcturus Therapeutics Holdings Inc.PHARMACEUTICAL PREPARATIONSwww.arcturusrx.com ↗

Price7.06

Change-4.79%

Gap-0.67%

Rel volume2.50×

Avg volume532.77K

Avg $ vol3.37M

SMA 206.11

SMA 506.78

SMA 2007.44

Price vs 50+4.13%

Price vs 200-5.24%

MA stackmixed

50/200 cross—

Supertrendup · 5.89

RSI (14)60

MACD hist0.19

MACD crossbull · 5d

Stoch %K / %D74 / 78

ADX (14)25

+DI / −DI30 / 15

RSI divergence—

MACD divergence—

ATR %+6.23%

ADR %5.40%

52w high23.16

52w low5.53

From 52w high-69.54%

Above 52w low+27.58%

New 52w highNo

SqueezeOff

Bollinger width28.55%

%B1.04

Donchian pos74.05%

Donchian high7.60

Donchian low5.50

AVWAP (52w high)8.35

vs AVWAP high-15.52%

AVWAP (52w low)6.43

vs AVWAP low+9.67%

OBV trendFlat

Chaikin MF (20)0.01

Today vs 20d2.50×

Avg vol (14d)522.39K

Avg vol (20d)532.77K

Avg $ vol (20d)3.37M

Market cap—

RS 3m (vs SPY)-22.44%

RS 6m (vs SPY)-8.56%

RS line new highNo

Trend template1/8

Technical rank45.3

1 week+17.58%

1 month+1.22%

3 months-23.48%

6 months-6.80%

1 year-41.11%

YTD+12.88%

P/E-3.21

P/B1.23

P/S2.57

P/FCF-2.83

EPS-2.40

Div yield—

ROE-38.29%

ROA-29.33%

Debt/Eq0.44

Current5.88

EV/EBITDA-1.30

Gross margin—

Net margin-80.19%

Rev growth-46.14%

EPS growth18.73%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value95.07M

Revenue2.96M

Net income-23.79M

Gross profit—

Free cash flow-74.5M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out28.42M

Employees111

ListedWed, May 22, 2013

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction34 / 100

Pattern quality—

Tech rank45.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.08

Support5.64

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARCT

All disclosures →

No recent disclosed trades by Congress in ARCT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARCT · 1 buy

Insider	Side	Shares	Value	Traded	Filed
MULROY DENNIS Chief Financial Officer · Employee Stock Option (right to buy) · 2026-05-01	Grant	100K	$0	2026-05-01	2026-05-07

SEC filings

EDGAR filings in ARCT · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.